On July 3, China Securities Regulatory Commission announced the approval of the first-time application of Scitop Bio-tech, a high-tech enterprise of food additives and probiotic products, for its A-share issuance on the Growth Enterprise Market, marking a successful completion of the company’s IPO. Therefore, the A-share market will welcome the first stock of probiotics.

The road to the IPO of Scitop Bio-tech is fairly tortuous that it took 20 months of auditing to gain the approval since the filing in October 2018, during which Scitop Bio-tech experienced the change of the audit committee, the implementation of the GEM registration system, and the epidemic pneumonia. (Source: Sina Finance)

Comments are closed.